bpze1

Vaccineexperimental

Clinical trial activity

6 trials · 11 clinical orgs · 0 marketing orgs

Phase 1
2
Phase 2
4
Phase 3
0
Phase 4
0

Earliest trial started Aug 1, 2010 (NCT01188512)

Timeline

2010s

  1. Jan 1, 2010

    Earliest Phase 1 Sponsor(trial)

  2. Jan 1, 2018

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • bpze1

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT05461131Phase 2Jun 20, 2022ILiAD Biotechnologies
NCT05116241Phase 2Nov 30, 2021ILiAD Biotechnologies
NCT03942406Phase 2Jun 15, 2019Advanced Clinical Research Inc., DM Clinical Research, ILiAD Biotechnologies, PPD, Rapid Medical Research, Inc.
NCT03541499Phase 2Sep 14, 2018National Institute of Allergy and Infectious Diseases (NIAID)
NCT02453048Phase 1Sep 1, 2015Institut National de la Santé Et de la Recherche Médicale, France, Karolinska Institute
NCT01188512Phase 1Aug 1, 2010European Union, Innogenetics, Institut National de la Santé Et de la Recherche Médicale, France, Karolinska Institute, Swedish Institute for Infectious Disease Control
Showing 6 of 6 trials
Page 1 / 1

Organizations

Research & Development (11)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
ILiAD BiotechnologiesFor profit3312019
Institut National de la Santé Et de la Recherche Médicale, FranceAcademic/Hospital2212010
Karolinska InstituteAcademic/Hospital2012010
Advanced Clinical Research Inc.For profit1012019
DM Clinical ResearchFor profit1012019
European UnionGovernment1012010
InnogeneticsFor profit1012010
National Institute of Allergy and Infectious Diseases (NIAID)Government1112018
PPDFor profit1012019
Rapid Medical Research, Inc.For profit1012019
Swedish Institute for Infectious Disease ControlGovernment1012010
11 organizations
Page 1 / 1